Brivaracetam as viable monotherapy option for focal and generalized epilepsy
Epilepsy & Behavior · 2026-10 · 183 · 111172
DOI: 10.1016/j.yebeh.2026.111172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026-10. Verfasst von Lena Bender und 1 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Center, University Medical Center, University of Freiburg, Germany. Electronic address: lena.bender@uniklinik-freiburg.de. Hauptthemen laut MEDLINE: Anticonvulsants, Pyrrolidinones, Epilepsy, Generalized, Epilepsies, Partial. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epilepsy Center, University Medical Center, University of Freiburg, Germany. Electronic address: lena.bender@uniklinik-freiburg.de.
- Epilepsy Center, University Medical Center, University of Freiburg, Germany.
Zitieren
APA
Bender, L., & Schulze-Bonhage, A. (2026). Brivaracetam as viable monotherapy option for focal and generalized epilepsy. Epilepsy & Behavior, 183, 111172. https://doi.org/10.1016/j.yebeh.2026.111172
Vancouver
Bender L, Schulze-Bonhage A. Brivaracetam as viable monotherapy option for focal and generalized epilepsy. Epilepsy & Behavior. 2026;183:111172. doi:10.1016/j.yebeh.2026.111172
BibTeX
@article{Bender2026,
author = {Bender, Lena and Schulze-Bonhage, Andreas},
title = {Brivaracetam as viable monotherapy option for focal and generalized epilepsy},
journal = {Epilepsy & Behavior},
year = {2026},
volume = {183},
pages = {111172},
doi = {10.1016/j.yebeh.2026.111172}
}
EUVIMED